PATENT CLAIM ANALYSIS

Application Number: 15905118
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "044000"]

Abstract:
The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.

Claim (Index 32):
The method of  claim 7 , wherein the fibrotic disorder is selected from the group consisting of pulmonary fibrosis, liver cirrhosis, scleroderma, glomerulonephritis, lung fibrosis, liver fibrosis, skin fibrosis, muscle fibrosis, radiation fibrosis, kidney fibrosis, proliferative vitreoretinopathy, and uterine fibrosis.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 88.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15041738', '14104450', '13120315', '13120342', '14278900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8821367518821067
- 35 USC 102 Novelty (BERT): 0.6897481431808639
- Combined Prediction Score: 0.8628978910119824
- Mean Citation Score: 700.4582519999999
- Max Citation Score: 723.1773
- Similarity Product: 692.5799705563006

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test